Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
2.290
-0.020 (-0.87%)
At close: Oct 23, 2026, 4:00 PM EDT
2.280
-0.010 (-0.44%)
After-hours: Oct 23, 2026, 7:30 PM EDT
Rocket Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, Rocket Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of $8.58. The average 1-year stock price forecast is 274.67% higher than the current stock price, while the lowest is $2.95 (+28.82%) and the highest is $15 (+555.02%).
Price Target: $8.58 (+274.67%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Rocket Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 6 | 6 | 6 |
| Buy | 0 | 0 | 0 | 0 | 1 | 1 |
| Hold | 6 | 6 | 6 | 6 | 5 | 6 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Total | 14 | 14 | 14 | 14 | 14 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Buy Reiterates $9 | Buy | Reiterates | $9 | +293.01% | Oct 8, 2026 |
| Goldman Sachs | Goldman Sachs | Hold Upgrades $3 → $4 | Hold | Upgrades | $3 → $4 | +74.67% | Oct 8, 2026 |
| Leerink Partners | Leerink Partners | Hold Reiterates $7 → $4 | Hold | Reiterates | $7 → $4 | +74.67% | Oct 7, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $15 | Buy | Maintains | $15 | +555.02% | Oct 7, 2026 |
| Wedbush | Wedbush | Buy Maintains $15 | Buy | Maintains | $15 | +555.02% | Oct 7, 2026 |
Financial Forecast
Revenue This Year
1.11M
Revenue Next Year
11.25M
from 1.11M
Increased by 915.60%
EPS This Year
-0.11
from -1.98
EPS Next Year
-1.30
from -0.11
EPS and Forward PE are based on non-GAAP adjusted numbers.